Here are five key facts:
1. RBC Capital has an “outperform” rating on Stryker shares.
2. Stryker has a market cap of $40.84 billion.
2. The P/E ratio is 28.97.
4. The company’s 52-week low is $86.68 and 52-week high is $113.85.
5. For the first quarter of 2016, Stryker reported net earnings reaching $402 million, up $79.5 million in the first quarter the year prior.
More device news:
Stryker’s net earnings up 79.5%; Orthopedics sales reach $1.1B: 9 key notes on Q1 2016
FDA clears Exatech’s Vantage Total Ankle — 5 highlights
Medtech’s ROSA system to be featured at AANS annual meeting — 3 quick notes
